Novozymes A/S (CPH:NSIS.B)
411.20
+1.00 (0.24%)
Jul 24, 2026, 4:59 PM CET
Novozymes Financials Overview
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 4,199 | 4,158 | 3,834 | 2,402 | 2,355 | 2,011 |
Revenue Growth | 3.49% | 8.45% | 59.58% | 1.99% | 17.14% | 6.46% |
Gross Profit Gross Profit Growth | 2,282 | 2,242 | 1,810 | 1,305 | 1,285 | 1,160 |
Operating Income Operating Income Growth | 818 | 816.7 | 501 | 533.6 | 612 | 538.87 |
Net Income Net Income Growth | 596.7 | 583.6 | 305.8 | 405.9 | 493.25 | 423.08 |
Earnings Per Share EPS Growth | 1.28 | 1.25 | 0.67 | 1.46 | 1.77 | 1.51 |
EPS Growth | 29.29% | 86.57% | -54.11% | -17.51% | 17.22% | 11.85% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Food & Beverages Food & Beverages Growth | 1,390 | 1,373 | 1,238 | 1,281 | - | - |
Human Health Human Health Growth | 493.6 | 494.8 | 429.9 | 439.7 | - | - |
Agriculture, Energy & Tech Agriculture, Energy & Tech Growth | 1,513 | 1,489 | 1,398 | 1,338 | 1,134 | 903.7 |
Household Care Household Care Growth | 801.9 | 801.2 | 767.7 | 685.2 | 670.66 | 640.14 |
Revenue (Total) Revenue (Total) Growth | 4,199 | 4,158 | 3,834 | 2,402 | 2,355 | 2,011 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 327.2 | 275.3 | 280 | 149.7 | 139.68 | 129.51 |
Total Debt Total Debt Growth | 3,212 | 3,005 | 1,797 | 1,044 | 932.42 | 832.18 |
Net Cash (Debt) Net Cash Growth | -2,885 | -2,730 | -1,517 | -894.3 | -792.74 | -702.67 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -6.19 | -5.84 | -3.30 | -3.22 | -2.84 | -2.51 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 1,282 | 1,222 | 1,020 | 557.1 | 537.53 | 546.27 |
Capital Expenditures CapEx Growth | -443.5 | -409.8 | -338.3 | -249.1 | -370.34 | -144.03 |
Free Cash Flow Free Cash Flow Growth | 838.7 | 811.7 | 681.6 | 308 | 167.19 | 402.24 |
Free Cash Flow Growth | 37.13% | 19.09% | 121.30% | 84.22% | -58.44% | -16.20% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 54.34% | 53.91% | 47.20% | 54.32% | 54.56% | 57.68% |
Operating Margin | 19.48% | 19.64% | 13.07% | 22.21% | 25.98% | 26.80% |
Pretax Margin | 17.99% | 17.88% | 10.88% | 21.84% | 25.96% | 26.25% |
Profit Margin | 14.21% | 14.04% | 7.98% | 16.98% | 21.00% | 21.04% |
FCF Margin | 19.97% | 19.52% | 17.78% | 12.82% | 7.10% | 20.01% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 6.500 | 0.870 | 0.830 | - | 0.807 | 0.740 |
Dividend Per Share Growth | 4.84% | 4.86% | - | - | 9.05% | 4.88% |
Dividend Yield | 1.58% | 1.58% | 1.00% | 2.78% | 1.57% | 0.98% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 43.03 | 43.68 | 81.60 | 34.04 | 26.68 | 47.83 |
Forward PE | 24.99 | 26.35 | 30.19 | 26.86 | 28.58 | 45.11 |
P/FCF Ratio | 30.56 | 31.34 | 22.45 | 44.75 | 78.12 | 49.75 |
PS Ratio | 6.10 | 6.12 | 3.99 | 5.74 | 5.55 | 9.95 |